human
antimicrobi
peptid
amp
repres
approxim
curat
amp
catalogu
human
host
defens
peptid
intrins
part
innat
immun
system
exhibit
broad
activ
spectrum
bacteria
fungi
virus
parasit
fig
also
toward
mammalian
malign
cell
repres
rel
larg
group
biomolecul
amp
antibacteri
abp
antifung
antiprotist
antivir
anticanc
antiparasit
insecticid
spermicid
chemotact
antioxid
proteas
inhibitor
even
exhibit
wound
heal
properti
support
inform
tabl
scope
action
overlap
consider
peptid
show
activ
sever
level
fig
instanc
one
hand
human
plasma
peptid
activ
multipl
bacteria
speci
human
urinari
gingiv
fluid
calcitonin
peptid
display
antimicrobi
activ
sever
bacteria
fungi
speci
human
neutrophil
peptid
hnp
defensin
isol
biolog
fluid
display
activ
sever
bacteri
fungal
viral
speci
fig
hand
dozen
human
amp
known
date
display
antimicrobi
activ
human
colon
pathogen
includ
escherichia
coli
pseudomona
aeruginosa
staphylococcu
aureu
fig
also
intrigu
observ
even
though
amp
display
broad
activ
spectra
other
seem
anywher
fig
like
confound
observ
bia
wherebi
speci
eg
e
coli
tend
test
frequent
other
observ
also
reflect
activ
spectra
amp
depend
physicochem
properti
group
accord
uniqu
famili
also
target
properti
environmentbiolog
fluid
found
larg
major
amp
identifi
date
abp
fig
concept
exampl
provid
review
base
result
studi
focus
abp
close
follow
deriv
studi
antivir
antifung
peptid
howev
principl
tend
appli
across
amp
amp
potent
cation
molecul
display
minimum
inhibitori
concentr
minimum
concentr
prevent
bacteri
growth
low
highlight
promis
antimicrobi
agent
furthermor
amp
act
rapidli
convent
antibiot
affect
typic
resist
mechan
involv
convent
drug
make
attract
therapeut
purpos
addit
amp
mere
microbicid
agent
scope
action
may
encompass
function
cellular
develop
immun
system
modul
instanc
fetal
keratinocyt
express
significantli
amp
compar
neonat
adult
keratinocyt
despit
lower
degre
exposit
environ
pathogen
agent
elev
level
amp
fetal
stage
develop
correl
increas
express
histon
demethylas
turn
also
play
key
role
sever
fundament
process
includ
chromatin
organ
cell
fate
commit
mesoderm
cardiac
muscl
endotheli
cell
differenti
hippocampu
also
tear
fluid
human
amp
cation
antimicrobi
protein
known
stimul
corneal
epitheli
cell
migrat
prolifer
respons
lacritin
glycoprotein
stimul
tear
secret
act
mitogen
cleav
also
display
antibacteri
thu
amp
appear
key
mediat
involv
sever
biolog
process
intrins
regul
tandem
fundament
process
work
togeth
maintain
organ
homeostasi
accordingli
amp
detain
innumer
properti
name
cytokin
modul
chemotaxi
angiogenesi
stimul
well
mast
cell
degranul
consequ
vasodilat
fibrinolysi
inhibit
tissu
injuri
prevent
inhibit
proteas
reinforc
wound
repair
inform
regard
interplay
amp
innat
immun
system
well
altern
role
given
beyond
scope
review
herein
revisit
antimicrobi
effect
human
amp
consid
wide
varieti
amino
acid
sequenc
structur
mechan
action
perform
function
perhap
surpris
discov
high
degre
conserv
analog
mechan
control
amp
format
regul
elimin
fact
process
dynam
involv
mani
substrat
precursor
proteasespeptidas
activ
inhibitor
major
amp
identifi
human
appear
result
cleavag
precursor
protein
unrel
function
rather
direct
transcript
translat
biolog
activ
peptid
nevertheless
amp
integr
element
innat
immun
system
product
protein
cleavag
repres
defens
strategi
invad
moreov
later
exemplifi
sever
amp
result
fragment
precursor
protein
act
synergist
order
fight
foreign
microorgan
sever
defens
barrier
fig
bioactiv
peptid
result
cleavag
protein
target
export
extracellular
milieu
peptid
precursor
protein
may
play
primari
function
process
requir
prior
commit
precursor
protein
secretori
pathway
ensu
presenc
signal
peptid
commit
secretori
pathway
peptid
modifi
sever
locat
time
point
begin
endoplasm
reticulum
move
golgi
apparatu
travel
insid
secretori
vesicl
end
secret
upon
fusion
vesicl
cytoplasm
prokaryot
microorgan
known
produc
amp
eg
microcin
bacteriocin
eg
vancomycin
daptomycin
knowledg
amp
format
human
even
amp
constitut
produc
secret
activ
level
constant
may
modul
action
proteolyt
enzym
contrast
circular
prokaryot
peptid
peptid
bond
connect
confer
enhanc
degre
stabil
human
amp
linear
natur
thu
consider
suscept
proteolyt
suscept
exploit
whole
set
proteolyt
endopeptidas
exopeptidas
capabl
mediat
format
elimin
amp
includ
kallikrein
kininas
matrix
metalloproteinas
cathepsin
interestingli
human
amp
subject
action
human
bacteri
enzym
exampl
bacteri
enzym
capabl
modul
human
amp
format
degrad
includ
metalloproteinas
aureolysin
glutamylendopeptidas
aureu
elastas
p
aeruginosa
gelatinas
enterococcu
faecali
metalloproteas
proteu
moreov
regul
human
amp
format
elimin
made
even
complex
one
consid
presenc
natur
occur
proteas
inhibitor
may
also
present
express
pattern
modul
antimicrobi
activ
natur
occur
lastli
peptid
inactiv
elimin
hydrolysi
also
intracellularli
recycl
clear
renal
filtrat
amp
tend
found
small
molecul
gener
compos
fewer
amino
acid
residu
frequent
l
configur
enantiom
result
distribut
function
group
around
central
carbon
atom
despit
mostli
cation
short
sequenc
human
amp
vari
anywher
amino
acid
human
neurokinin
consist
ten
human
consist
amino
acid
present
hydrophob
content
net
charg
vari
peptid
respect
furthermor
predict
ration
particular
amp
accomplish
biolog
activ
done
detail
inform
avail
given
inform
amp
tend
organ
group
facilit
rational
sever
criteria
use
classifi
sort
amp
includ
origin
size
sequenc
biolog
class
mechan
action
secondari
structur
amino
acid
sequenc
secondari
structur
import
factor
take
perhap
allow
us
predict
peptid
interact
molecul
rough
estim
amp
catalogu
date
support
inform
tabl
indic
follow
peptid
present
helic
howev
approxim
amp
current
identifi
known
structur
known
structur
neither
helix
exclud
unknown
structur
amp
either
andor
suggest
highli
conserv
structur
highli
primordi
biolog
function
secondari
structur
human
amp
may
includ
eg
eg
defensin
extend
peptid
eg
indolicidin
consid
polypeptid
chain
typic
contain
three
ten
amino
acid
per
strand
residu
per
turn
respect
amino
acid
sequenc
virtual
unlimit
one
easili
envis
given
peptid
display
multitud
secondari
structur
thu
mani
divers
conform
see
protein
secondari
structur
predict
approach
among
secondari
structur
addit
frequent
encount
natur
regular
predict
consequ
extens
studi
amp
linear
notabl
posit
charg
amphipath
adopt
secondari
conform
upon
bind
bacteri
therefor
antimicrobi
activ
directli
depend
secondari
contrast
amp
possess
conform
due
presenc
disulfid
bridg
form
thiol
group
cystein
peptid
bridg
often
requir
antimicrobi
contrariwis
bovin
lactoferricin
shown
effect
e
coli
even
bridg
block
human
amp
human
present
specif
case
disrupt
three
stabil
disulfid
bond
compromis
antimicrobi
activ
diminish
chemotact
properti
furthermor
correl
conform
peptid
antimicrobi
activ
alway
straightforward
one
could
imagin
exampl
disrupt
disulfid
bond
result
peptid
free
cystein
carboxi
termin
show
increas
antimicrobi
activ
pathogen
candida
albican
commens
bifidobacterium
moreov
linear
extend
peptid
keep
fix
conform
solut
enrich
one
amino
acid
particularli
arginin
prolin
tryptophan
instanc
amp
histatin
found
human
saliva
enrich
histidin
prophenin
rich
prolin
phenylalanin
come
loop
rich
peptid
presenc
mani
prolin
make
amp
much
less
like
form
amphipath
structur
adopt
frequent
refer
polyprolin
helic
ppii
structur
structur
specif
bound
domain
usual
found
protein
interact
protein
mediat
assembl
specif
protein
complex
upon
peptid
bind
human
antibacteri
peptid
abp
compos
largest
group
human
amp
exhibit
weight
averag
net
charg
per
peptid
consider
averag
net
charg
amp
identifi
date
also
despit
intuit
posit
charg
amp
potenc
human
amp
show
greater
potenc
efficaci
compar
speci
suggest
environ
presenc
differ
amino
acid
rare
amino
acid
also
play
signific
role
notwithstand
larg
divers
amp
across
human
biolog
fluid
fig
tabl
note
amp
much
divers
across
speci
identifi
human
present
rather
conserv
properti
fact
amp
speci
character
intrigu
sequenc
structur
physicochem
properti
case
point
bacillu
subtili
known
produc
sever
extrem
potent
lipopeptid
activ
concentr
low
antimicrobi
activ
sever
speci
one
gageotetrin
uniqu
anion
amp
consist
leucin
glutam
acid
residu
conjug
uniqu
fatti
acid
anoth
exampl
sonorensin
bacillu
sonorensi
amp
heterocycloanthracin
subfamili
activ
bacteria
includ
listeria
monocytogen
aureu
sonorensin
display
amino
acid
sequenc
multipl
copi
motif
make
peptid
rather
baceridin
circular
peptid
bacillu
synthes
machineri
bear
six
amino
acid
moreov
baceridin
proteasom
inhibitor
compromis
cell
cycl
progress
induc
apoptosi
tumor
cell
copsin
coprinopsi
cinerea
bactericid
enterococcu
faecium
l
monocytogen
interact
peptidoglycan
precursor
lipid
ii
interf
cell
wall
curious
modifi
pyroglutam
confer
higher
degre
thermal
stabil
resist
toward
proteas
even
though
display
fungicid
virucid
properti
chief
activ
human
amp
bacteria
fig
furthermor
amp
repres
extrem
divers
group
biolog
activ
molecul
share
common
properti
contribut
membranolyt
otherwis
antimicrobi
activ
posit
charg
hydrophob
amphiphil
therefor
mechan
action
amp
involv
membran
disrupt
fig
process
also
requir
transloc
warrant
respect
target
local
interact
amp
bacteri
membran
depend
establish
attract
electrostat
forc
bacteri
speci
known
carri
neg
charg
outer
membran
due
phosphat
group
lipopolysaccharid
bacteria
lipoteicho
acid
fact
bacteria
display
type
neg
charg
lipid
account
lack
specif
abp
promot
attract
amp
bacteri
membran
prevent
bind
host
cell
membran
moreov
inher
hydrophob
amphiphil
allow
abp
form
cluster
membran
surfac
low
concentr
low
ratio
abp
tend
adsorb
onto
surfac
adopt
orient
parallel
membran
bilay
howev
cluster
increas
ratio
subsequ
promot
addit
cluster
certain
ratio
threshold
reach
abp
adopt
perpendicular
orient
rel
bacteri
membran
allow
insert
discuss
fig
peptid
adopt
mani
differ
secondari
structur
conform
depend
amino
acid
sequenc
well
environ
consequ
differ
peptid
differ
environ
favor
format
uniqu
structur
barrel
stave
carpet
toroid
peptid
attach
insert
membran
bilay
hydrophob
region
align
phospholipid
acyl
group
hydrophil
region
creat
central
region
pore
barrel
stave
form
addit
structur
act
primer
aggreg
new
peptid
thu
expand
pore
due
abp
cation
site
membran
crossov
would
energet
unfavor
origin
parallel
orient
howev
orient
chang
perpendicular
one
upon
abp
cluster
peptid
reorient
hydrophob
portion
face
membran
acyl
group
cation
site
face
interior
pore
thu
cluster
pore
format
provid
mean
membran
disrupt
leakag
intracellular
molecul
bacteri
contrast
peptid
remain
parallel
membran
surfac
hydrophob
residu
face
membran
hydrophil
residu
face
surround
milieu
carpet
structur
achiev
organ
membran
rigid
weaken
progress
new
peptid
ad
culmin
dissolut
breakup
mechanist
mode
action
less
stringent
peptid
need
adopt
specif
structur
howev
necessari
concentr
abp
appear
much
higher
requir
format
barrel
toroid
pore
form
peptid
need
aggreg
onto
membran
surfac
insert
perpendicular
subsequ
abp
reorient
parallel
membran
polar
residu
interact
polar
head
membran
lipid
thu
caus
membran
bend
induc
bend
bilay
caus
upper
lower
leaflet
meet
allow
mixtur
peptid
lipid
head
group
line
interior
pore
form
toroid
wormhol
abp
may
also
inhibit
bacteri
growth
bactericid
effect
promot
cluster
anion
lipid
phosphatidylglycerol
pg
cardiolipin
instanc
initi
believ
act
accord
carpet
model
evid
fragment
name
act
magnet
compet
neg
charg
pg
promot
redistribut
domain
phospholipid
reorgan
may
disturb
cell
signal
compromis
activ
protein
name
potassium
channel
serious
jeopard
bacteria
likewis
peptid
deriv
lactoferricin
shown
induc
defect
e
coli
cell
divis
rearrang
distribut
inner
membran
phospholipid
essenti
due
cluster
cardiolipin
anion
bia
toward
posit
charg
confer
amp
abil
easili
interact
biolog
membran
also
neg
charg
molecul
fig
nucleic
acid
bear
phosphat
addit
type
interact
larg
unspecif
amp
exhibit
activ
also
multipl
mechan
action
fig
instanc
lactoferricin
known
inhibit
multidrug
efflux
pump
well
dna
rna
protein
ten
human
amp
deriv
lactoferricin
lysozym
thought
sequenc
homolog
act
trap
replic
fork
prevent
base
recombin
dna
furthermor
presenc
mani
prolin
peptid
also
known
ppii
structur
aforement
hamper
organ
amphipath
structur
favor
interact
peptid
structur
nucleic
acid
thu
play
major
role
signal
transduct
complex
howev
ppii
structur
necessarili
contain
abp
rich
arginin
residu
also
abl
transloc
across
membran
interact
nucleic
acid
protein
henc
prolin
andor
abp
may
capabl
inhibit
prosynthet
signal
pathway
enzymat
activ
fig
shift
conform
cellular
structur
activ
autolysin
howev
specul
warrant
studi
addit
target
bacteri
membran
human
defensin
also
bind
peptidoglycan
precursor
lipid
ii
inhibit
cell
wall
biosynthet
enzym
staphylococci
moreov
stabil
disulfid
bridg
conserv
cystein
residu
human
amp
conform
disrupt
result
linear
peptid
still
maintain
antimicrobi
properti
despit
lose
membranolyt
antifung
histatin
act
multipl
level
mechan
action
conserv
across
histatin
famili
amp
histatin
potent
amp
famili
amp
bind
yeast
transmembran
receptor
protein
intern
target
primarili
yeast
lead
format
reactiv
oxygen
speci
ro
caus
atp
efflux
inhibit
oxid
simultan
histatin
also
interact
potassium
transport
caus
releas
k
ion
atp
function
domain
histatin
synthet
multipli
antifung
activ
significantli
potenti
becam
significantli
compar
normal
histatin
observ
might
prove
use
indic
modul
number
function
domain
per
amp
may
enhanc
antimicrobi
activ
without
requir
administr
increas
quantiti
amp
histatin
may
also
exert
antimicrobi
activ
inhibit
host
microorganism
proteolyt
enzym
histatin
strong
inhibitor
human
matrix
metalloproteas
metalloproteas
porphyromona
thu
inhibitori
activ
proteolyt
enzym
may
attenu
tissu
damag
microbi
propag
onset
periodont
inflammatori
diseas
also
inhibit
cystein
proteas
clostripain
clostridium
histolyticum
histatin
mitig
virul
factor
produc
clostridium
speci
may
therefor
allevi
complic
associ
ga
gangren
far
mechan
action
discuss
context
abp
antifung
peptid
sometim
peptid
activ
bacteria
fungi
turn
action
antivir
peptid
diverg
mechan
thu
independ
comment
fig
although
overlap
exist
extracellularli
nativ
antivir
peptid
often
present
structur
primarili
lytic
activ
envelop
virus
directli
inactiv
virion
fig
human
lysozym
fragment
group
prototyp
capabl
aggreg
viral
surfac
caus
disrupt
membran
similarli
peptid
appear
exert
antivir
activ
destruct
viru
envelop
type
herp
simplex
viru
hsv
even
disrupt
capsid
howev
membran
lipid
envelop
virus
deriv
host
cell
membran
special
attent
requir
consid
exploit
featur
antivir
peptid
may
disrupt
host
cell
membran
indiscrimin
altern
antivir
peptid
may
block
interact
viru
host
cell
fig
believ
least
part
mechan
action
human
defensin
human
virip
cyclic
lactoferricin
serin
proteas
inhibitor
elafin
instanc
demonstr
human
hd
prevent
hsv
infect
block
viru
bind
entri
antivir
activ
attribut
high
affin
hsv
glycoprotein
b
avid
toward
endogen
heparan
similarli
protect
hiv
confer
peptid
lectin
properti
bind
viral
envelop
glycoprotein
crucial
viral
attach
fusion
envelop
host
membran
subsequ
entri
host
bind
block
action
eg
pseudogen
retrocyclin
togeth
human
peptid
target
repres
exampl
likewis
infect
also
block
retrocyclin
bind
tightli
glycoprotein
cyclic
peptid
lactoferricin
seem
compet
ligat
extracellular
heparan
sulfat
chondroitin
sulfat
thu
prevent
first
event
cytomegaloviru
hsv
papillomaviru
final
elafin
thought
act
indirectli
host
cell
hamper
viral
attach
probabl
modul
host
antivir
inflammatori
respons
toward
synergist
mechan
antivir
peptid
also
bind
inhibit
activ
viral
lead
inhibit
viral
attach
inhibit
viral
infect
promot
intern
virucid
peptid
may
also
preclud
sever
step
viral
replic
interact
intracellular
target
fig
case
may
prevent
hsv
replic
bind
directli
also
arrest
influenza
viru
replic
inhibit
protein
kinas
c
phosphoryl
essenti
step
nuclear
traffick
human
cathelicidin
deriv
peptid
turn
inhibit
revers
transcriptas
viral
proteas
thu
prevent
integr
viral
genet
load
human
resist
mechan
amp
demonstr
far
among
microorgan
observ
almost
exclus
bacteria
except
bacteria
seem
develop
complet
resist
cation
abp
though
strategi
exist
among
bacteri
speci
diminish
potenc
efficaci
difficulti
acquir
resist
may
stem
mainli
fact
abp
target
essenti
cellular
compon
bacteria
surviv
easili
modul
cell
without
caus
signific
advers
effect
therefor
resist
mechan
like
limit
therapeut
util
abp
light
scarc
resist
mechan
de
novo
acquisit
mechan
bacteria
natur
developpossess
abp
first
one
consid
primari
target
abp
consist
bacteri
cell
membran
bear
mind
abp
depend
electrostat
interact
membran
neg
charg
posit
peptid
residu
accordingli
bacteria
learn
modul
cell
membran
charg
composit
bacteria
partial
modifi
peptidoglycan
teichoic
acid
bacteria
partli
chang
lipopolysaccharid
lipid
moieti
thu
compromis
interact
instanc
enzym
transfer
protein
known
transport
posit
charg
surfac
anion
teichoic
acid
aureu
reduc
neg
net
charg
outer
also
aureu
system
increas
express
mprf
dltabcd
gene
upon
exposur
cation
amp
aureu
strain
mutat
regul
gene
disturb
strain
becom
suscept
daptomycin
polymyxin
b
hnp
platelet
factor
peptid
less
infecti
vivo
nonclin
endocard
gene
product
mprf
attach
lysin
residu
bear
posit
charg
group
anion
phophatidylglycerol
make
less
neg
charg
thu
less
suscept
interact
cation
vibrio
cholera
increas
resist
polymyxin
modifi
lipopolysaccharid
process
mediat
lpta
gene
product
found
gonococc
speci
bacteria
neisseria
gonorrhoea
protect
lipopolysaccharid
lipid
moieti
attach
phosphoethanolamin
make
bacteria
less
suscept
amp
increas
capac
modul
host
immun
respons
evad
cellular
moreov
n
gonorrhoea
neisseria
meningitid
presenc
phosphoryl
phosphoethanolamin
lipid
moieti
enhanc
activ
pathway
product
proinflammatori
cytokin
human
cell
amplifi
despit
virul
absenc
modif
commens
neisseria
speci
allow
colon
coexist
human
host
without
induc
bactericid
host
immun
addit
adapt
composit
henc
electrostat
properti
membran
order
circumv
host
immun
system
exclus
phenomenon
pathogen
bacteria
commens
bacteria
intestin
tract
remov
phosphat
group
membran
lipopolysaccharid
decreas
neg
charg
allow
greater
surviv
prolifer
similarli
paradox
virul
mutat
commens
gut
microbiota
bacteroid
fail
remov
phosphat
group
lipopolysaccharid
kill
inflamm
normal
strain
keep
therefor
appear
invers
relationship
acquir
resist
bacteri
virul
inducedacquir
modif
render
cell
less
virul
simultan
allow
easili
colon
coexist
within
human
host
environ
second
bacteria
also
abl
adapt
fluiditi
membran
increas
hydrophob
interact
within
outer
membran
thu
hinder
pore
third
bacteria
express
proteas
abp
transport
efflux
pump
like
cassett
abc
transport
circumv
innat
defens
proteas
produc
aureu
induc
loss
antibacteri
activ
neuroendocrin
peptid
chromofungin
procatestatin
human
catestatin
enzymat
degrad
treat
bacteri
e
faecali
bacitracin
bind
abc
transport
interact
regulatori
domain
system
increas
express
confer
resist
system
regul
express
abc
transport
constitut
transport
permeas
sensor
kinas
howev
least
b
subtili
abc
transport
requir
sens
resist
bacitracin
suggest
transport
also
function
environment
lastli
bacteria
may
also
synthes
molecul
capabl
directli
neutral
provid
way
bacteria
bypass
amp
howev
resist
mechan
limit
resist
amp
take
place
larg
extent
disulfid
bound
occur
cystein
peptid
consist
amino
acid
adopt
conform
human
neutrophil
express
four
distinct
known
despit
initi
isol
peripher
blood
leukocyt
also
found
bone
marrow
spleen
remain
two
alreadi
identifi
human
found
paneth
cell
small
intestin
epitheli
cell
thu
tissu
express
aforement
cell
type
amp
also
found
bodili
fluid
direct
contact
cell
among
recent
discoveri
found
activ
bifidobacterium
adolescenti
anaerob
gut
commens
directli
bacteriostat
bactericid
pathogen
bacteria
may
therefor
play
import
role
maintain
balanc
among
microbiota
similarli
human
particularli
potent
bacillu
clostridium
difficil
one
common
pathogen
respons
nosocomi
infect
whose
highli
virul
strain
often
attack
small
intestin
addit
may
show
cellular
region
specif
throughout
gastrointestin
tract
either
secret
activ
insid
intracellular
granul
constitut
express
amen
also
emphas
activ
spectrum
limit
bacteria
fungi
exhibit
activ
sever
viru
includ
hiv
hsv
adenoviru
human
papillomaviru
hpv
display
sever
uniqu
mechan
action
pleas
refer
section
note
antimicrobi
activ
influenc
even
differ
one
amino
acid
fact
addit
acid
residu
lower
effect
accur
potenc
aureu
p
aeruginosa
e
coli
explain
easili
donat
proton
make
defensin
less
posit
charg
least
consid
interact
domain
thu
reinforc
import
posit
net
charg
antimicrobi
activ
evidenc
section
term
diseas
known
paramount
role
particularli
demand
defens
mechan
increas
accordingli
remark
increas
concentr
smaller
extent
human
tear
report
ocular
surgeri
increas
allow
peptid
reach
requir
concentr
antimicrobi
activ
follow
decreas
heal
complet
demand
immun
defens
return
nonetheless
goal
achiev
increas
concentr
tear
restrict
enhanc
immun
defens
also
known
promot
local
cellular
prolifer
tissu
parallel
salivari
activ
streptococcu
mutan
secret
found
deregul
human
contrast
prolong
physic
exercis
shown
significantli
increas
level
salivari
show
lifestyl
may
consider
impact
defens
microorgan
possibl
modul
activ
thereof
disulfid
bound
occur
cystein
defensin
longer
span
amino
acid
also
share
conform
first
hbd
isol
plasma
sampl
kidney
constitut
major
sourc
sinc
peptid
deriv
human
identifi
tear
urin
vagin
lavag
sweat
blood
plasma
effect
primarili
e
turn
isol
psoriat
skin
display
bactericid
activ
toward
e
coli
p
aeruginosa
c
albican
bacteriostat
activ
toward
aureu
despit
effect
vitro
present
attenu
activ
vivo
result
sensit
physiolog
salin
contrast
activ
aureu
e
faecium
even
physiolog
salt
defensin
found
semin
plasma
report
potenti
efficaci
e
coli
aureu
c
furthermor
identifi
epididym
fluid
shown
regul
inflamm
toward
e
coli
aureu
c
albican
protect
sperm
motil
diseas
condit
increas
concentr
hbd
plasma
bronchoalveolar
lavag
fluid
report
patient
diffus
panbronchiol
particular
suggest
play
role
p
also
express
throughout
gastrointestin
tract
seem
evolv
togeth
chang
human
gut
bacteria
display
characterist
express
pattern
respons
certain
microorgan
express
may
significantli
alter
human
diseas
notabl
inflammatori
bowel
diseas
insight
review
topic
pleas
refer
enhanc
inflammatori
condit
ocular
role
ph
amp
activ
consid
serv
illustr
role
salt
concentr
fact
tear
contain
remark
concentr
sodium
chlorid
inhibit
activ
human
amp
case
inhibit
increas
presenc
whole
tear
fluid
suggest
presenc
inhibit
factor
therefor
whenev
increas
demand
amp
activ
eg
upon
infect
tissu
damag
concentr
must
surg
reach
requir
protect
level
howev
excess
increas
concentr
amp
may
lead
tissu
damag
local
function
may
compromis
reason
complex
interplay
amp
requir
surfac
like
ocular
epithelia
achiev
qualit
enrich
addit
expect
quantit
increas
depict
multitud
amp
found
human
tear
pleas
refer
similarli
activ
spectrum
limit
bacteria
fungi
activ
sever
viru
name
hiv
influenza
viru
iav
respiratori
syncyti
viru
vaccinia
viru
display
sever
uniqu
mechan
action
depend
target
see
section
mechan
action
lastli
genom
studi
predict
addit
express
human
cell
presenc
human
bodili
fluid
antimicrobi
activ
vivo
yet
adopt
conform
shorter
sequenc
adopt
complet
circular
conform
stabil
disulfid
bound
cystein
peptid
rhesu
prototyp
recent
discov
famili
amp
like
possess
microbi
activ
bacteria
fungi
also
capabl
protect
mononuclear
cell
infect
moreov
peptid
display
antivir
activ
hsv
hiv
iav
sever
acut
respiratori
syndrom
sar
coronaviru
act
sever
mechan
depend
structur
peptid
interest
odd
repres
first
cyclic
peptid
famili
discov
anim
albeit
human
moreov
circular
structur
appear
requir
antimicrobi
peptid
first
isol
antimicrobi
octadecapeptid
express
leukocyt
rhesu
monkey
format
result
join
two
independ
acid
peptid
deriv
truncat
contrast
previous
describ
class
defensin
human
thought
complet
inactiv
despit
exist
mrna
encod
least
two
express
bone
gene
encod
human
also
encod
prematur
stop
codon
thu
hamper
express
synthet
human
call
retrocyclin
shown
promis
antivir
fact
inhibit
entri
hiv
hsv
iav
host
cell
mammal
also
protect
infect
bacillu
anthraci
spore
rhesu
protect
mice
sar
coronaviru
cathelicidin
divers
group
cation
amphipath
amp
exhibit
activ
bacteria
fungi
term
cathelicidin
origin
refer
entir
precursor
protein
though
current
commonli
use
whole
famili
includ
result
peptid
antimicrobi
activ
contrast
mammalian
trend
cathelicidin
defensin
main
amp
one
human
gene
encod
multipl
locat
chromosom
express
airway
mouth
tongu
esophagu
epididymi
small
despit
tissu
express
pattern
constitut
form
spleen
liver
stomach
intestin
bone
marrow
highli
posit
charg
charg
physiolog
ph
due
high
content
arginin
lysin
amino
acid
adopt
structur
solut
ionic
composit
similar
human
defensin
share
common
structur
featur
peptid
highli
heterogen
despit
deriv
precursor
cathelicidin
character
highli
conserv
signal
peptid
cathelin
domain
highli
variabl
antimicrobi
domain
releas
cleavag
cathelicidin
cleav
antimicrobi
peptid
kallikrein
kallikrein
serin
proteas
upregul
vitamin
shown
significantli
reduc
risk
death
infect
dialysi
shown
disrupt
bacteri
membran
format
toroid
pore
carpet
exhibit
chemotact
properti
attract
leukocyt
activ
secret
chemokin
addit
intern
cell
acidifi
endosom
activ
signal
pathway
downstream
receptor
interact
profil
airway
fluid
collect
prematur
infant
tracheal
aspir
infect
evidenc
product
even
earli
stage
sampl
found
significantli
increas
concentr
pulmonari
system
infect
suggest
peptid
import
avoid
infecti
process
fight
alreadi
establish
concentr
measur
semin
plasma
sampl
healthi
donor
found
higher
blood
furthermor
found
attach
spermatozoa
elicit
possibl
role
human
fertil
precursor
extens
cleav
high
concentr
serin
proteas
present
semin
altern
form
human
cathelicidin
peptid
contain
one
alanin
initi
found
produc
femal
vagin
secret
due
action
gastricsin
sperm
precursor
activ
bacteria
e
coli
aureu
p
aeruginosa
bacillu
megaterium
synergist
peptid
semin
plasma
play
essenti
defens
role
protect
human
reproduct
interestingli
citrullin
adp
adenosin
diphosph
arginin
compromis
abil
prevent
sepsi
perhap
attach
neg
charg
molecul
reduc
peptid
cation
rais
steric
histatin
normal
compon
human
saliva
part
innat
immun
system
protect
broad
array
infecti
agent
especi
candida
speci
saccharomyc
cerevisia
cryptococcu
neoforman
neurospora
two
gene
encond
histatin
locat
chromosom
exclus
express
human
salivari
howev
activ
amp
result
cleavag
histatin
also
histatin
encod
gene
histatin
product
posttransl
proteolyt
cleavag
histatin
though
histatin
also
result
posttranscript
modif
histatin
peptid
deriv
histatin
bear
distinct
domain
associ
specif
function
name
domain
antimicrobi
activ
domain
properti
histatin
two
import
motif
consist
copper
ii
nickel
ii
motif
zinc
ii
motif
although
also
bind
cobalt
ii
abil
coordin
metal
ion
appear
import
stabil
secondari
structur
particularli
presenc
neg
charg
nevertheless
histatin
lack
defin
secondari
structur
unord
aqueou
solut
assum
structur
organ
addit
histatin
bind
copper
ii
nickel
ii
ion
induc
format
ro
contribut
fungicid
histatin
bind
receptor
fungal
cell
membran
induc
cell
death
disrupt
cell
cycl
caus
nonlyt
loss
atp
discuss
histatin
effect
potent
amp
sever
antimicrobi
speci
peptid
nontox
human
cell
human
microflora
may
due
fact
transloc
across
membran
site
speci
parotid
submandibular
sublingu
gland
secret
histatin
concentr
secret
shown
decreas
age
even
account
total
protein
moreov
oral
candid
infect
increas
age
suggest
link
defici
human
histatin
increas
risk
oral
dermcidin
anion
amp
appar
homolog
known
amp
peptid
group
compris
amino
acid
residu
subsequ
process
smaller
still
activ
one
dermcidin
constitut
express
human
eccrin
sweat
gland
secret
sweat
exhibit
antimicrobi
activ
common
human
pathogen
microorgan
aureu
staphylococcu
epidermidi
e
coli
e
faecali
c
constitut
product
contrast
human
defensin
cathelicidin
induc
inflammatori
stress
condit
small
percentag
human
breast
cancer
cell
display
rna
encod
dermcidin
oxid
stress
induct
differ
type
tumor
cell
lead
product
divers
biolog
activ
proteolyt
process
dermcidin
therefor
upregul
dermicidin
may
confer
human
breast
cancer
cell
select
advantag
compar
nonmalign
cell
contrast
reduc
express
dermcidin
sweat
atop
dermat
patient
contribut
skin
infect
alter
skin
henc
downregul
dermicidin
atop
dermat
patient
may
repres
suppress
innat
fundament
defens
mechan
turn
could
confer
advantag
infecti
microorgan
unlik
histatin
nontox
human
cell
human
microflora
see
dermicidin
seriou
deleteri
consequ
human
host
dermcidin
isoform
known
oxid
protein
capabl
inhibit
synthesi
nitric
oxid
endotheli
cell
insulin
pancreat
islet
hepat
hormon
also
hypertens
patient
show
significantli
higher
level
plasma
dermcidin
salicyl
acid
shown
reduc
dermcidin
level
simultan
attenu
insulin
inhibit
patient
acut
myocardi
therefor
exploit
dermcidin
isoform
antimicrobi
therapeut
purpos
like
possibl
due
sever
side
effect
despit
may
promis
therapeut
target
hypertens
diabet
manag
anim
model
dermcidin
shown
induc
platelet
aggreg
coronari
arteri
diseas
activ
platelet
cyclooxygenas
inhibit
constitut
form
nitric
oxid
synthas
respect
effici
time
higher
adp
activ
notabl
dermcidin
abl
stimul
develop
coronari
arteri
diseas
one
anim
model
even
suboptim
concentr
adp
within
togeth
observ
suggest
abil
amp
fight
infect
depend
induct
infecti
microorgan
particular
peptid
gener
local
environmenttissu
act
also
biolog
role
perform
human
amp
divers
immedi
expect
play
essenti
function
fight
infecti
microorgan
fact
inhibit
insulin
uniqu
sens
protein
known
arrest
pancreat
insulin
synthesi
way
similar
observ
might
result
novel
unexpect
applic
human
amp
amp
express
human
liver
leap
initi
discov
human
blood
subsequ
found
urin
peptid
known
hepcidin
character
high
content
cystein
residu
approxim
residu
eight
disulfid
bound
essenti
maintain
iron
homeostasi
mutat
lead
sever
iron
overload
juvenil
hepcidin
main
regul
plasma
iron
concentr
secret
promot
inflammatori
respons
particularli
action
interleukin
one
main
mediat
acut
phase
iron
bioavail
limit
factor
bacteri
growth
hepcidin
repres
organ
mechan
sequest
iron
invas
pathogen
howev
sever
iron
sourc
avail
happen
within
human
host
elimin
singl
reservoir
may
suffici
attenu
microorgan
virul
moreov
bacteria
known
exploit
almost
everi
host
protein
reservoir
consequ
human
laepshepcidin
rather
limit
sourc
antimicrobi
reason
antimicrobi
role
iron
sequestr
depend
hepcidin
also
sever
mediat
transferrin
lactoferrin
ceruloplasmin
haptoglobin
hemopexin
mutat
respons
decreas
level
hepcidin
compromis
function
regul
iron
homeostasi
major
histocompat
complex
class
like
hereditari
hemochromatosi
protein
hfe
transferrin
receptor
ferroportin
lead
increas
iron
blood
level
level
high
enough
produc
hemochromatosi
individu
increas
risk
infecti
complic
includ
bacteremia
mening
caus
e
bacterem
cellul
hemorrhag
bullou
skin
lesion
caus
v
multipl
pyogen
abscess
liver
parenchyma
result
yersinia
enterocolitica
mening
endocard
pericard
result
infect
l
fatal
septicemia
infect
vibrio
contrast
hemochromatosi
also
associ
decreas
macrophag
iron
storag
case
hemochromatosi
deplet
make
cell
effici
fight
salmonella
enterica
subsp
enterica
serovar
typhimurium
mycobacterium
tuberculosi
howev
protect
effect
macrophag
iron
storag
deplet
demonstr
anim
model
appear
mediat
hepcidin
rather
reduc
avail
iron
salmonella
transferrin
lactoferrin
compromis
iron
acquisit
neuropeptid
neuroendocrin
peptid
may
exert
mitogen
action
innat
barrier
reinforc
may
display
neurotransmitt
immunoregulatori
direct
antimicrobi
activ
first
natur
antifung
chromogranin
deriv
fragment
peptid
first
isol
chromaffin
secretori
granul
bovin
adren
howev
sequenc
highli
conserv
human
ident
homolog
microbi
activ
also
overlap
extent
bovin
irrespect
human
display
antimicrobi
activ
bacteria
micrococcu
luteu
b
megaterium
larg
varieti
filament
fungi
n
crassa
aspergillu
fumigatu
alternaria
brassicola
nectria
haematococca
fusarium
culmorum
fusarium
oxysporum
trichophyton
mentagrophyt
yeast
cell
cerevisia
c
albican
moreov
mani
autocrin
paracrin
biolog
activ
chromogranin
precursor
protein
attribut
peptid
locat
along
sequenc
catecholamin
chromaffin
cell
upon
stimul
found
human
bodili
therefor
antimicrobi
activ
spectrum
may
extend
peptid
also
form
chromogranin
proteolyt
cleavag
coproduc
peptid
even
potent
addit
structur
requir
antimicrobi
activ
chromogranin
deriv
peptid
posttransl
modif
may
also
modul
activ
instanc
alkyl
modif
consist
addit
pyridylethyl
moieti
function
group
cystein
residu
disrupt
disulfid
bridg
render
select
activ
b
megaterium
luteu
oxid
seem
render
inact
bacteria
still
activ
fungi
addit
chromogranin
deriv
peptid
also
undergo
phosphoryl
glycosyl
modul
physicochem
properti
current
known
store
endocrin
neuroendocrin
neuron
cell
releas
stimul
chromaffin
immun
cell
upon
stress
moreov
stimul
polymorphonuclear
immun
cell
induc
process
chromogranin
secret
chromogranin
deriv
may
account
local
inflamm
lastli
recombin
synthet
human
fragment
shown
inhibit
vascular
contract
induc
parathyroid
hormon
secret
neuron
surviv
express
neurofila
neuron
gaba
adrenomedullin
first
isol
human
adren
pheochromocytoma
plasma
concentr
rais
specif
physiolog
condit
name
renal
peptid
antibacteri
activ
sever
bacteria
includ
propionibacterium
acn
aureu
luteu
p
gingivali
actinomyc
naeslundii
mutan
c
albican
eikenella
corroden
actinobacillu
actinomycetemcomitan
streptococcu
pneumonia
haemophilu
influenza
streptococcu
pyogen
bacteroid
fragili
e
coli
helicobact
human
neuropeptid
display
antimicrobi
activ
bacteria
fungi
truncat
fragment
tenfold
potent
intact
precursor
neuropeptid
perhap
net
charg
fragment
posit
intact
encephalin
deriv
peptid
may
either
enhanc
inhibit
immun
respons
correspond
circul
immun
cellsmedi
human
anim
well
subsequ
antimicrobi
effect
may
thu
take
place
indirectli
immun
system
modul
simultan
antibacteri
assay
reveal
peptid
benkelytin
fragment
proenkephalin
specif
target
bacteria
includ
luteu
b
megaterium
luteu
aureu
effect
classic
proenkephalin
ascrib
secretori
granul
adren
medullari
chromaffin
cell
variou
brain
region
striatum
pituitari
accord
anim
despit
also
demonstr
express
secret
polymorphonuclear
neutrophil
account
particular
enrich
wound
fluid
b
lymphocyt
macrophag
mast
howev
note
antimicrobi
effect
encephalin
deriv
peptid
result
mostli
anim
studi
adequ
studi
human
secret
despit
high
conserv
sequenc
across
speci
like
contribut
similar
activ
spectrum
even
phosphoryl
glycosyl
characterist
possibl
envis
differ
level
posttransl
modif
result
gene
diverg
may
result
distinct
activ
spectra
interestingli
peptid
benkelytin
metabol
vivo
opioid
peptid
thu
reveal
intric
relationship
innat
immun
pain
modul
plasma
concentr
increas
coronari
arteri
bypass
graft
express
immun
neuron
cell
possibl
stimuli
may
act
cell
popul
therebi
account
immun
system
modul
peripheri
alter
central
nervou
system
signal
howev
exact
role
mechan
interplay
clear
addit
amp
found
epitheli
secret
gut
skin
exampl
includ
peptid
deriv
hormon
activ
aureu
c
accordingli
evid
suggest
amp
like
act
inhibit
mrna
protein
synthesi
rather
induc
direct
membran
disrupt
case
sever
cation
protein
display
nonenzymat
antimicrobi
activ
sustain
result
cleavag
peptid
protein
fragment
exampl
lactoferrin
glycoprotein
enrich
milk
neutrophil
granul
abil
sequest
iron
thu
prevent
bacteri
digest
pepsin
lactoferrin
yield
lactoferricin
h
human
amp
abl
neutral
bacteri
toxin
regul
gene
transcript
inhibit
complement
activ
viral
infect
tumor
overgrowth
thu
extend
antimicrobi
properti
human
chemokin
secret
macrophag
polymorphonuclear
immun
cell
therefor
found
blood
moreov
allerg
inflammatori
respons
bacteri
infect
airway
chemokin
gener
mast
cell
proteas
activ
sever
airway
pathogen
includ
pneumonia
aureu
h
peptid
result
cleavag
pepsinogen
c
prosequ
also
shown
exert
antimicrobi
activ
although
initi
identifi
stomach
bullfrog
synthes
human
pepsinogen
c
prosequ
similar
structur
characterist
amphipath
helic
structur
cleavag
peptid
also
exhibit
antimicrobi
calcitermin
amp
result
cleavag
amino
acid
long
sequenc
region
protein
calgranulin
c
isol
human
airway
adopt
conform
bacteri
membran
calcitermin
abl
target
bacteria
eg
e
coli
p
aeruginosa
fungi
eg
c
albican
furthermor
precursor
protein
fragment
peptid
may
act
synergist
protect
human
host
foreign
microorgan
present
airway
one
hand
cleavag
peptid
calcitermin
insert
membran
microorgan
hand
precursor
protein
calgranulin
c
proinflammatori
activ
act
molecular
pattern
molecul
bind
receptor
advanc
glycat
end
product
innat
immun
cell
activ
signal
pathway
lead
product
proinflammatori
cytokin
histamin
upregul
cell
adhes
molecul
recruit
leukocyt
degranul
peptid
dcd
ssl
lek
letter
correspond
first
three
amino
acid
correspond
precursor
dermcidin
protein
also
form
eccrin
sweat
gland
apocrin
sweat
gland
bodi
site
high
probabl
contact
pathogen
eg
palm
face
arm
exhibit
antimicrobi
activ
larg
number
microorgan
includ
aureu
e
faecali
e
coli
epidermidi
pseudomona
putida
aureu
amp
regul
proteolyt
process
sever
level
see
section
differenti
express
inflammatori
condit
peptid
resist
proteolyt
degrad
sweat
least
hr
interestingli
peptid
anion
natur
distinct
properti
may
lead
differ
antimicrobi
activ
spectrum
unclear
though
surpris
skin
repres
harsh
particularli
uniqu
environ
specif
interest
note
consensu
averag
skin
surfac
ph
decreas
last
year
gener
accept
shower
cosmet
product
decreas
skin
surfac
ph
plain
tap
water
increas
skin
ph
notic
neg
charg
seem
import
peptid
antimicrobi
activ
contrast
would
expect
amp
fact
peptid
natur
anion
low
ph
high
h
concentr
lead
increas
net
charg
toward
posit
therefor
acid
skin
actual
keep
resid
bacteri
flora
attach
alkalin
skin
compromis
attach
suggest
neg
charg
skin
peptid
alkalin
skin
effici
despit
averag
length
residu
net
charg
close
amp
alreadi
identifi
human
amp
tend
longer
posit
charg
amp
amino
acid
identifi
across
six
kingdom
life
curious
approxim
half
appear
human
origin
present
amino
acid
sequenc
residu
averag
suggest
larg
amp
human
featur
moreov
compar
remain
amp
larg
human
amp
tend
bias
toward
leucin
lysin
residu
display
nonpolar
aliphat
posit
charg
side
group
respect
tabl
therefor
larg
human
amp
enrich
amino
acid
promot
distinguish
featur
amp
high
overal
posit
charg
hydrophob
domain
amphiphil
nevertheless
bia
toward
lysin
residu
neither
uniqu
human
amp
pronounc
among
instanc
amphibian
cathelicidin
compos
lysin
residu
homolog
snake
crotalicidin
contain
lysin
residu
show
high
potenc
pyogen
acinetobact
baumannii
e
faecali
aureu
e
coli
klebsiella
pneumonia
p
evidenc
tabl
larg
human
amp
found
varieti
bodili
fluid
includ
tear
saliva
urin
airway
secret
breast
milk
blood
sweat
epididym
fluid
addit
larg
amp
also
expect
exist
despit
constitut
found
biolog
fluid
due
induc
natur
instanc
paneth
cell
small
intestin
releas
granul
upon
stimul
cholinerg
bacteri
granulocyt
known
contain
amp
granul
destin
extracellular
therefor
synthesi
secret
larg
amp
may
constitut
amen
induct
microbi
macromolecul
inflammatori
cytokin
stimuli
sever
larg
amp
may
yet
catalogu
henc
explor
novel
larg
antimicrobi
human
peptid
ongo
work
may
yield
novel
therapeut
agent
peptidom
complet
studi
global
analysi
peptid
present
biolog
sampl
given
time
particular
condit
identif
natur
occur
amp
human
biolog
fluid
labori
daunt
sometim
unsuccess
task
natur
occur
peptid
directli
result
gene
encod
passag
bodili
fluid
result
cellular
damag
renew
extracellular
proteolyt
process
precursor
protein
latter
consid
preval
hamper
identif
interpret
biolog
activ
amp
precursor
protein
may
display
antimicrobi
activ
may
also
cleav
multipl
function
nonfunct
moreov
owe
larg
depend
amp
sequenc
structur
peptid
subject
mass
spectrometri
ms
base
approach
employ
enzymat
chemic
digest
neither
vitro
step
may
caus
fragment
instead
proteom
strategi
prefer
classic
differ
peptid
fraction
separ
test
biolog
activ
often
without
ever
address
peptid
biologicalantimicrobi
activ
sequenc
target
hypothet
mechan
action
howev
current
strategi
focus
precis
inform
capabl
address
paramet
sometim
singl
studi
see
human
biolog
fluid
consist
complex
sampl
contain
lipid
salt
protein
carbohydr
molecul
make
studi
endogen
peptid
extrem
difficult
consequ
enrich
separ
step
almost
alway
requir
biomolecul
protein
larger
peptid
well
salt
complic
separ
target
peptid
luckili
salt
sometim
remov
procedur
appli
protein
remov
first
foremost
proteasespeptidas
inactiv
done
denatur
procedur
eg
microwav
boil
ad
proteasepeptidas
howev
modifi
peptid
structur
thu
step
avoid
sampl
resist
enough
proteasepeptidas
activ
case
urin
sampl
exampl
collect
long
subject
proteolyt
process
bladder
protein
frequent
remov
select
precipit
commonli
organ
solvent
eg
aceton
acid
eg
trichloroacet
acid
precipit
also
remov
salt
left
supernat
howev
protein
remov
complet
may
lead
format
peptid
aggreg
consequ
lost
sinc
peptid
present
great
varieti
size
sequenc
structur
hydrophob
properti
net
charg
characterist
isol
complex
still
complex
allow
isol
step
take
place
multipl
dimens
increas
peptid
isol
effici
accuraci
instanc
peptid
first
isol
base
size
bia
toward
specif
amino
acid
eg
cystein
tryptophan
methionin
presenc
modif
ptm
eg
phosphopeptid
glycopeptid
still
aforement
limit
search
endogen
amp
human
bodili
fluid
mostli
reli
identif
candid
amp
chromatograph
techniqu
eg
liquid
chromatographi
hplc
sequenc
eg
edman
sequenc
follow
de
novo
chemic
synthesi
vitro
antimicrobi
activ
test
reason
identif
vivo
test
novel
amp
often
time
consum
requir
multipl
studiesphas
resourc
order
mitig
problem
candid
human
amp
come
first
predict
multipl
way
includ
mine
entir
human
genom
particular
motif
known
confer
antimicrobi
activ
screen
human
peptidom
eg
salivari
urinari
order
find
homolog
peptid
known
amp
accordingli
sever
librari
databas
current
avail
data
comparison
search
program
even
combin
previous
obtain
data
de
novo
even
identif
amp
benefit
combin
chromatograph
immunolog
techniqu
genom
proteom
genom
proteom
allow
predict
novel
amp
potenti
contribut
larger
number
put
amp
peptid
proven
vivo
antimicrobi
activ
accur
identifi
combin
chromatograph
immunolog
techniqu
chemic
sequenc
antimicrobi
assay
though
immunoassay
detect
intend
target
varieti
complex
biolog
sampl
techniqu
provid
integr
view
peptidom
suffer
lack
specif
issu
requir
previou
knowledg
target
moreov
issu
becom
particular
problem
consid
shorter
longer
peptid
result
precursor
protein
may
contain
epitop
thu
recogn
peptid
fragment
despit
exhibit
distinct
biolog
activ
electrospray
ioniz
esi
laser
desorpt
ioniz
maldi
frequent
success
appli
ioniz
techniqu
field
bodili
fluid
peptidom
line
peptid
frequent
previous
separ
capillari
electrophoresi
ce
base
approach
allow
differ
peptid
fraction
independ
point
onward
almost
mass
analyz
use
although
practic
quadrupol
ion
trap
instrument
frequent
util
one
peptidom
especi
exploratori
turn
fourier
cyclotron
suitabl
targetedconfirmatori
analysi
deal
fewer
apparatus
allow
tandem
ms
perform
peptid
readili
sequenc
addit
identif
circumv
limit
concern
immunolog
assay
larg
simplifi
peptidom
workflow
summari
aim
isol
particular
peptid
predict
known
charg
molecular
weight
procedur
theoret
straightforward
first
fluid
sampl
requir
sometim
multipl
centrifug
step
remov
cell
cellular
debri
wast
possibl
contamin
protein
peptid
supernat
separ
fraction
multidimension
chromatograph
techniqu
within
procedur
protein
peptid
initi
fraction
gel
filtrat
size
dimens
follow
charg
dimens
fraction
chromatographi
use
neg
charg
ion
exchang
resin
affin
molecul
net
posit
charg
salt
gradient
use
separ
peptid
interest
bound
peptid
base
predict
isoelectr
point
final
peptid
subject
ms
analysi
typic
ioniz
esi
maldi
subsequ
analyz
hybrid
ltq
amp
tend
highli
basic
peptid
due
bia
toward
arginin
lysin
residu
propens
particularli
enrich
appli
cation
exchang
chromatographi
base
howev
biolog
fluid
complex
matric
sometim
requir
multipl
fraction
isol
extract
step
labori
optim
techniqu
detect
quantif
amp
despit
inher
complex
often
base
alway
accur
function
structur
predict
recent
approach
prove
capabl
isol
peptid
present
bodili
fluid
bind
directli
certain
bacteri
membran
compon
lipopolysaccharid
induc
inflammatori
respons
obtain
bacteri
homogen
extract
membran
compon
organ
solvent
function
bead
agaros
use
affin
protein
chromatographi
conjug
membran
bacteri
compon
incub
human
biolog
fluid
eg
saliva
urin
peptid
bound
conjug
bead
elut
analyz
hybrid
fourier
transform
apparatu
moreov
function
bead
conjug
bacteri
membran
compon
test
vivo
capac
induc
product
inflammatori
mediat
thu
exploratori
approach
could
result
identif
potenti
human
amp
select
properti
capabl
bind
bacteri
membran
induc
inflammatori
respons
recent
dalla
colleagu
attain
complet
prolif
analysi
natur
occur
peptid
potenti
antimicrobi
activ
human
milk
tandem
mass
spectrometri
msm
search
librari
human
milk
peptid
known
order
remov
milk
peptid
produc
vitro
proteolysi
fresh
milk
deriv
peptid
compar
control
sampl
origin
immedi
subject
boil
boil
denatur
proteas
vitro
proteolysi
take
place
peptid
present
control
could
confid
assign
origin
analysi
moreov
mass
fragment
first
round
msm
exclud
subsequ
round
author
realiz
uniqu
natur
occur
peptid
identifi
confid
yet
unknown
function
serv
illustr
much
still
discov
regard
biolog
role
human
endogen
peptid
biolog
fluid
nevertheless
antimicrobi
activ
milk
peptid
predict
amp
confirm
vivo
radial
diffus
assay
e
coli
furthermor
studi
reinforc
observ
background
mass
spectra
search
seem
critic
factor
mass
analyz
ioniz
techniqu
use
come
number
peptid
identifi
confid
assign
studi
author
emphas
demonstr
import
avoid
vitro
hydrolysi
amp
human
bodili
fluid
attain
ad
proteas
inhibitor
sampl
collect
adequ
account
phenomenon
author
use
appropri
control
contrast
bodili
fluid
seem
suscept
degre
hydrolysi
least
extent
urin
instanc
thought
stabl
requir
treatment
proteas
howev
time
urin
collect
alreadi
remain
stagnant
consider
longer
period
time
henc
probabl
alreadi
extens
expos
action
proteasespeptidas
inher
present
urin
therefor
intact
urinari
amp
actual
alway
question
ideal
interpret
consid
background
hydrolyt
enzym
present
urin
sampl
also
question
inhibit
proteolysi
semin
plasma
sampl
fact
liquefact
process
human
semen
perform
seminin
proteolyt
enzym
therefor
natur
occur
amp
analyz
sampl
allow
liquefi
without
addit
proteas
inhibitor
curious
seminin
primari
agent
respons
liquefact
semin
coagulum
partial
destroy
freez
reinforc
vital
analyz
fresh
sampl
similarli
degrad
peptid
fragment
deriv
semenogelin
semin
plasma
sampl
time
depend
respons
declin
activ
sperm
underscor
import
time
perform
analys
peptid
bodili
previous
state
amp
activ
depend
larg
structur
correct
character
becom
paramount
import
best
experiment
techniqu
current
crystallographi
nuclear
magnet
allow
studi
relationship
though
expens
therefor
current
commonli
replac
complement
bioinformat
predict
tool
whenev
possibl
use
tool
sequenc
amino
acid
peptid
allow
accur
immedi
predict
presenc
secondari
structur
eg
overal
structur
devis
algorithm
employ
energi
minim
principl
molecular
dynam
sometim
result
multipl
mutual
exclus
conform
accord
peptid
dynam
structur
biolog
common
identif
softwar
referenc
literatur
peptideprecursor
protein
identif
sequest
current
howev
consider
need
algorithm
softwar
capabl
correctli
identifi
amp
predict
relationship
amp
promis
replac
convent
antibiot
owe
effect
multiresist
bacteria
multipl
bacteri
speci
simultan
invok
divers
set
mechan
easili
shortcut
bacteria
fungi
andor
viru
ideal
amp
would
highli
select
target
leav
human
host
cell
unaffect
ii
prone
resist
mechan
iii
rel
easi
produc
low
cost
iv
stabl
storag
upon
administr
drug
design
amp
focus
peptid
nonpeptid
mimet
drug
modul
hydrophob
posit
amphiphil
endogen
amp
increas
antimicrobi
potenc
howev
exploit
amp
therapeut
purpos
actual
complex
initi
envis
linear
amp
present
simpler
design
predict
relationship
circular
peptid
may
allow
design
longer
act
resist
amp
peptid
design
insert
intend
amp
circular
peptid
cyclotid
proven
efficaci
hiv
inflammatori
diseas
circumv
instabl
poor
similarli
human
produc
amp
acid
antimicrobi
activ
may
depend
action
endogen
enzym
act
upon
amino
acid
produc
amp
acid
may
render
resist
hydrolysi
rather
administ
exogen
amp
possibl
perhap
secur
control
pharmacolog
stimul
product
endogen
amp
instanc
activ
vitamin
success
use
induc
express
defensin
beta
camp
cation
antimicrobi
peptid
gene
product
human
cell
cultur
keratinocyt
diabet
foot
ulcer
promot
wound
accordingli
persist
function
milk
human
plasma
human
infant
human
milk
feed
serv
purpos
exogen
administ
amp
without
requir
de
novo
amp
help
prevent
biofilm
format
microorgan
growth
case
fragment
alreadi
shown
antibiofilm
format
properti
sever
aureu
strain
p
aeruginosa
common
pathogen
infect
well
melioidoisi
etiolog
agent
burkholderia
pseudomallei
uropathogen
e
anoth
amp
antibiofilm
format
activ
found
prevent
develop
epidermidi
aureu
biofilm
larg
respons
orthoped
implant
associ
likewis
amp
may
also
inhibit
format
fungal
biofilm
instanc
histatin
demonstr
success
inhibit
growth
c
albican
biofilm
dentur
exampl
may
broaden
applic
amp
clinic
biomed
field
allow
function
cathet
altern
implant
medic
devic
also
reduc
bacteri
colon
biofilm
format
infect
rate
present
long
last
function
activ
minim
cytotox
human
human
amp
could
theoret
also
use
biosensor
immobil
onto
microchip
identif
purpos
allow
identif
microorgan
howev
applic
exploit
anim
synthet
amp
biosensor
electr
imped
alter
result
presenc
bacteri
fungal
surfac
element
specif
peptid
nucleic
acid
probe
target
present
higher
versatil
lower
cost
lower
sensit
limit
compar
convent
altern
amp
could
use
drug
deliveri
system
form
conjug
order
accur
target
drug
agent
tumor
site
intend
organ
typifi
monodispers
endosomolyt
nanoparticl
vivo
gene
deliveri
use
intraven
inject
function
nanoparticl
higher
membran
penetr
target
function
may
allow
deeper
tissu
penetr
increas
antimicrobi
potenc
sustain
releas
novel
rout
administr
achiev
ever
sinc
isol
first
peptid
frog
skin
sever
breakthrough
made
isol
synthesi
applic
amp
still
mani
challeng
yet
overcom
field
amp
reflect
mainli
huge
divers
littl
known
behavior
vivo
relationship
term
cost
produc
amp
sever
hundr
time
expens
product
convent
moreov
amp
design
complex
quest
perfect
amp
search
fact
consid
possibl
work
amino
acid
small
peptid
ten
amino
acid
could
differ
sequenc
larger
peptid
amino
acid
could
present
differ
sequenc
one
amino
acid
could
adopt
one
differ
sequenc
possibl
even
account
presenc
posttransl
modif
one
peptid
could
shape
sever
differ
secondari
structur
fall
wide
spectrum
activ
depend
milieu
condit
furthermor
way
overcom
challeng
peptid
stabil
one
consid
possibl
synthes
administ
amp
contain
acid
thu
decreas
suscept
hydrolysi
human
deal
larg
amount
amino
acid
combin
one
mind
use
peptid
librari
comput
model
quantit
relationship
analysi
order
narrow
larg
collect
surrog
amp
review
pleas
see
blondel
lohner
anoth
challeng
overcom
lower
amp
activ
vivo
compar
observ
vitro
larg
hamper
develop
amp
therapeut
agent
decreas
activ
stem
differ
ph
salt
concentr
presenc
proteas
correspond
inhibitor
interact
molecul
hinder
antimicrobi
activ
accordingli
sever
amp
eg
neuprex
reach
phase
ii
clinic
trial
fail
approv
market
evid
superior
activ
alreadi
market
convent
antibiot
earli
clinicaltrialsgov
registri
result
databas
publicli
privat
support
clinic
studi
human
particip
conduct
around
world
list
clinic
trial
involv
amp
instanc
current
studi
efficaci
melanoma
patient
due
abil
stimul
immun
system
chromogranin
deriv
peptid
scrutini
therapeut
potenti
dental
diseas
simultan
therapeut
strategi
also
studi
augment
amp
express
patient
defici
believ
due
increas
lymphocyt
deriv
cytokin
decreas
one
exampl
strategi
pimecrolimu
calcineurin
inhibitor
bind
high
affin
prevent
transloc
nuclear
factor
activ
cell
nucleu
transcript
releas
inhibitori
cytokin
trial
reader
access
clinicaltrialsgov
anoth
possibl
caveat
concern
cytotox
mammalian
cell
concentr
natur
occur
valu
bacteria
produc
amp
also
develop
mean
avoid
target
peptid
efflux
pump
sequest
enzym
howev
eukaryot
cell
equal
prone
damag
administr
exogen
amp
carri
high
enough
concentr
therefor
administ
amp
constitut
produc
concentr
normal
found
human
host
environ
toxic
detriment
human
cell
furthermor
rapid
metabol
low
bioavail
characterist
amp
peptid
suffer
extens
proteolysi
vivo
therebi
account
inactiv
short
similarli
peptid
avail
site
distant
origin
would
cross
mani
cellular
membran
howev
due
amp
polar
membran
hydrophob
may
prevent
moreov
contrast
highli
polar
mediat
eg
ionic
salt
metabolit
endogen
peptid
tend
transport
compromis
bioavail
differ
compart
subsequ
imposs
absorb
gastrointestin
tract
therefor
number
possibl
rapidli
escalad
therapi
optim
base
modul
chemic
properti
engin
deliveri
system
even
acknowledg
factor
human
host
certainli
unpredict
environ
peptid
may
behav
differ
display
uniqu
individu
pharmacokinet
pharmacodynam
final
note
due
amp
interact
depend
immun
mediat
variabl
like
result
immun
statu
alter
frequent
found
human
diseas
includ
infecti
one
taken
togeth
discuss
result
support
amp
constitut
paramount
group
defens
molecul
human
biolog
fluid
present
fluid
contribut
steril
notabl
enrich
biolog
fluid
bath
tissu
largest
load
microorgan
fig
saliva
urin
also
amp
seem
display
activ
spectra
hand
microorgan
other
display
effect
thu
express
activ
pattern
human
amp
enrich
biofluid
may
suffer
select
pressur
result
expos
microorgan
specif
present
fluid
fig
